| P50 | author | Lori Laffel | Q65054904 |
| P2860 | cites work | The effect of continuous glucose monitoring in well-controlled type 1 diabetes | Q37269538 |
| | Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes | Q37400821 |
| | Perceived accuracy in continuous glucose monitoring: understanding the impact on patients | Q42077167 |
| | Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes | Q42605976 |
| | Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial | Q42992091 |
| | Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes | Q43001906 |
| | Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years | Q43189388 |
| | Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy | Q46142750 |
| | Continuous glucose monitoring and intensive treatment of type 1 diabetes | Q46380752 |
| | The Draize test and modifications | Q46876174 |
| | Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring | Q56093368 |
| | Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research | Q72082832 |
| | A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose | Q74150701 |
| | Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring | Q83383308 |
| | Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study | Q84488091 |
| | Statistical methods for assessing agreement between two methods of clinical measurement | Q26778461 |
| | Acceptability and utility of the mySentry remote glucose monitoring system | Q28686176 |
| | Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas | Q30384396 |
| | Evaluating clinical accuracy of systems for self-monitoring of blood glucose | Q30463253 |
| | Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry | Q30956324 |
| | Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial | Q33556781 |
| | Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial | Q33803598 |
| | Outpatient glycemic control with a bionic pancreas in type 1 diabetes | Q34283269 |
| | Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes | Q34407187 |
| | The T1D Exchange clinic registry | Q34418645 |
| | Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes | Q34482263 |
| | Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines | Q34557730 |
| | Real-life utilization of real-time continuous glucose monitoring: the complete picture | Q35336885 |
| | Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase | Q35408311 |
| | A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years | Q35688182 |
| | Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth | Q35986175 |
| | Continuous glucose monitoring in children with type 1 diabetes | Q36098103 |
| | Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm | Q36159093 |
| | The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial | Q36353388 |
| | Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study | Q36398699 |
| | A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite | Q36608965 |
| | FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group | Q36627309 |
| | Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes | Q36879509 |
| | A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system | Q37192444 |
| P921 | main subject | glycobiology | Q899224 |
| | glucose monitoring | Q95987978 |
| P304 | page(s) | S223-33 | |
| P577 | publication date | 2016-02-01 | |
| P1433 | published in | Diabetes technology & therapeutics | Q26853929 |
| P1476 | title | Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies | |
| P478 | volume | 18 Suppl 2 | |